Lhasa Limited is pleased to announce the release of the Vitic 2024.1 database, supporting organisations leading the way in the pharmaceutical, cosmetic, and agrochemical industries, with toxicity risk assessments.
Vitic is a structure-searchable database containing over 500,000 expertly curated and peer-reviewed data records. Continuously expanding, it provides high-quality data on a variety of toxicological endpoints, including carcinogenicity, genotoxicity, and skin sensitisation.
Exploring the latest improvements
In the latest update, 16,338 new data records have been added, bringing the total to 574,566. Additionally, 272 new substances have been introduced, raising the overall substance count to 23,505.
Updates to the Lhasa summary calls now cover substances for both in vivo and in vitro skin sensitisation data. Furthermore, the Lhasa reliability score has been added to in vitro sensitisation data, indicating the extent to which studies adhere to recognised guidelines.
Watch this video featuring Business Partnerships Manager, Lina Din, to learn how Vitic can enhance carcinogenicity risk assessments.
Vitic is available for a free trial, contact Lhasa to learn more.